Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use

Fig. 4

Workflow for elutriated fraction RO for the quantification of percent monocytes. a Cells from the final product from a healthy donor after the addition of interferons were gated on singlets, followed by CD45+ cells, live cells, and then the CD15Lin population. Total monocytes were counted as the combination of Classical (CD14+), intermediate (CD14+CD16+), and non-classical CD14/dimCD16+. b Shows the backgating of the monocyte population. c Analysis of the same product from a after 4 h incubation at room temperature. d Shows the backgating strategy as in b

Back to article page